Deborah Knobelman - Jun 3, 2024 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Financial Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/4/2024, 05:02 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +164K $0.00 164K Jun 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +246K $0.00 246K Jun 3, 2024 Common Stock 246K $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest and become exercisable on June 3, 2025 and the remaining shares shall vest in 36 equal monthly installments as of the last calendar day of each month thereafter.